Funders & Partners
NeuroGenE receives core funding from the Stanley Centre for Psychiatric Research at the Broad Institute of Harvard and MIT. To date, we have received further support from the Wellcome Centre for Ethics and Humanities (WEH), University of Oxford. Our aim is to attract a small group of committed funders, who will help to ensure that we achieve our core goal of establishing a world-class model for sustainable and integrated research, capacity-building and training initiatives in the ethics of global neuropsychiatric research.
The Broad Institute aims to improve global human health through genomics, to allow a greater understanding of biology, treatments of human disease, and to lay the foundations for a new generation of therapies. The Stanley Centre focuses on the genomics of psychiatric disorders, with the aim of contributing to new understandings of pathogenesis, the identification of biomarkers, and ultimately to generate new treatments. NeuroGenE exists because of the vision and support of Dr Steven E Hyman, Director of the Stanely Centre, and Dr Karestan C Koenen, Principal Investigator of the Stanley Global Collections Initiative.
The University of Oxford, Department of Psychiatry was ranked the top Department of Psychiatry in the United Kingdom in the most recent Research Excellence Framework. The Department provides a visionary intellectual home for NeuroGenE, showcasing international leadership in substantive integration of science and ethics in an academic research setting.
The Oxford Wellcome Centre for Ethics and Humanities (WEH) was launched in 2017. It aims to provide fresh understanding of ethical concepts and challenges in light of contemporary science innovations, specifically in data-driven science, genomics and neuroscience. WEH co-funds researchers in NeuroGenE and offers an interdisciplinary platform to support current and future researchers and capacity building initiatives in this area.
If you would like to find out more about NeuroGenE, contact us here.